Godavari Drugs Allots 7.86 Lakh Equity Shares on Warrant Conversion

Godavari Drugs Ltd announced the allotment of 7,86,690 equity shares following the conversion of warrants. This conversion was approved by the Board of Directors on August 14, 2026. The shares were issued on a preferential basis to the 'Promoters Category' at an issue price of ₹89 per share, including a premium of ₹10. The company received the balance 75% of the issue price, amounting to ₹5,25,11,557.5, from the allottees. This allotment increases the company's paid-up equity capital from ₹10,12,74,350 to ₹10,91,41,250. The new shares rank pari-passu with existing equity shares. A total of 15,73,375 warrants remain outstanding for conversion.